KISTA VA MIOMA: ENDOKRINOLOGIK VA GORMONAL SABABLAR
Keywords:
cyst, fibroid, endocrine factors, hormonal imbalance, reproductive hormones, gynecological disorders, diagnosis, treatment, hormonal regulationAbstract
This study explores the endocrine and hormonal factors contributing to the development of cysts and fibroids in women. It discusses the role of hormonal imbalances, reproductive hormones, and other endocrine disruptions in the formation and growth of these common gynecological conditions. The paper also reviews current approaches to diagnosis and treatment, emphasizing the importance of hormonal regulation in managing cysts and fibroids effectively.
References
1. Berek, J. S., Novak, E., & Berek, & Novak’s Gynecology. (2020). Wolters Kluwer.
2. Azziz, R., Carmina, E., Chen, Z., et al. (2009). Polycystic Ovary Syndrome. Nature Reviews Disease Primers, 1, 15026.
3. Bulun, S. E. (2013). Uterine Fibroids. New England Journal of Medicine, 369(14), 1344–1355.
4. Goodman, N. F., Cobin, R. H., Futterweit, W., et al. (2015). American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Polycystic Ovary Syndrome. Endocrine Practice, 21(11), 1291-1300.
5. Pritts, E. A., Parker, W. H., & Olive, D. L. (2009). Fibroids and Reproductive Function. Obstetrics and Gynecology, 113(6), 1235-1246.
6. Practice Committee of the American Society for Reproductive Medicine. (2017). Treatment of uterine fibroids. Fertility and Sterility, 108(3), 416-423.
7. Speroff, L., & Fritz, M. A. (2010). Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins.
8. Lumsden, M. A., Hamoodi, I., Gupta, J. K., & Hickey, M. (2015). Fibroids: Diagnosis and Management. BMJ, 351, h4887.
9. Teede, H. J., Misso, M. L., Costello, M. F., et al. (2018). Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction, 33(9), 1602-1618.
10. Lee, T. Y., & Kim, S. H. (2018). Role of Hormones in the Pathogenesis of Uterine Leiomyoma. Endocrinology and Metabolism Clinics of North America, 47(2), 345-356.
11. Mayo Clinic Staff. (2023). Uterine Fibroids. Retrieved from https://www.mayoclinic.org/diseases-conditions/uterine-fibroids/symptoms-causes/syc-20354288
12. American College of Obstetricians and Gynecologists (ACOG). (2020). Practice Bulletin No. 228: Management of Symptomatic Uterine Leiomyomas.
13. Barash, J., & Oehninger, S. (2014). Polycystic Ovary Syndrome: Current Perspectives. Therapeutics and Clinical Risk Management, 10, 509-517.
14. Lethaby, A., Vollenhoven, B., & Sowter, M. (2008). Fibroids and Infertility: A Systematic Review. Best Practice & Research Clinical Obstetrics & Gynaecology, 22(4), 603-615.
15. Khan, Z., & Stewart, E. A. (2013). Uterine Fibroids: A Review of Current Treatment Options. Current Opinion in Obstetrics and Gynecology, 25(6), 450-455.
